Obesity clinical trials in Louisiana
34 studies for Obesity are looking for participants at sites in Louisiana.
Cities in Louisiana
- Baton Rouge17 studies
- New Orleans8 studies
- Shreveport7 studies
- Metairie5 studies
- Monroe4 studies
- Lafayette4 studies
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Southern Clin Research, Zachary
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07668414Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- BRCR Global Louisiana, Gretna
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT07837973A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Velocity Clinical Research, Lafayette
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT06672549Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Care Access - New Iberia, New Iberia
- Louisiana Research Center, Shreveport
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Care Access - New Iberia, New Iberia
- Louisiana Research Center, Shreveport
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937086A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Care Access - Lake Charles (Bayou Pines), Lake Charles
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07321886Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Cardiovascular Associates Research, LLC, Covington
- Tandem Clinical Research - Marrero, Marrero
RecruitingPhase 3
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Monroe
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Clinical Trials Management, LLC d/b/a Flourish Research, Metairie
- IMA Clinical Research Monroe - Armand, Monroe
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Care Access - Shreveport 2, Shreveport
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07369011A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- IMA Clinical Research Monroe - Armand, Monroe
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07392190Pennington Generation Cohort
- Pennington Biomedical Research Center, Baton Rouge
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Sep 17, 2026 · NCT06849206A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Baton Rouge
- AURORA-2 Clinical Site, Metairie
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Baton Rouge
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743463Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Our Lady of the Lake Medical Center, Baton Rouge
- Louisiana Heart Center - Hammond, Covington
- Heart Clinic of Hammond, Hammond
- and 1 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 16, 2026 · NCT07037459A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Ascension DePaul Health, New Orleans
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351045A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Elevate Clinical Research, Lake Charles
- Nola Care Clinical Research Center, Metairie
- DelRicht Clinical Research, LLC, New Orleans
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351058Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Velocity Clinical Research - Baton Rouge, Baton Rouge
- Tandem Clinical Research - Marrero, Marrero
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684235Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Shreveport
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07284901Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Kailera Clinical Site, Shreveport
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07284979A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Pennington Biomed Res Ctr, Baton Rouge
RecruitingPhase 3
Ages 8 to 18 · All sexes · Updated Aug 31, 2026 · NCT07253285Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Pennington Biomedical Research Center, Baton Rouge
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Aug 27, 2026 · NCT07575399A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Grace Research, LLC, Bossier City
- Horizon Research Group of Opelousas, LLC, Eunice
- Cardiovascular Institute of the South, Houma
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001Collaborative Multi-level Obesity Intervention Engaging Communities Trial
- InclusivCare - Avondale Clinic, Avondale
- CommuniHealth Services - Bastrop Clinic, Bastrop
- CareSouth Medical and Dental - Baton Rouge Clinic, Baton Rouge
- and 15 more
Recruiting
Ages 18 to 75 · All sexes · Updated Aug 11, 2026 · NCT06835686Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Baton Rouge
RecruitingPhase 3
Ages 18 to 79 · All sexes · Updated Aug 10, 2026 · NCT07654361A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Tandem Clinical Research, Marrero
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Jul 22, 2026 · NCT07477704Low Oxygen Exposure and Weight Status
- Pennington Biomedical Research Center, Baton Rouge
RecruitingHealthy volunteers welcome
Ages 22 to 65 · All sexes · Updated Jul 16, 2026 · NCT05289310Body Composition Outcomes in MS Patients
- Pennington Biomedical Resarch Center, Baton Rouge
- Pennington Biomedical Research Center, Baton Rouge
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT07530718Experimental Approach to Test Predictions of Body Weight Regulation Models
- Pennington Biomedical Research Center, Baton Rouge
RecruitingHealthy volunteers welcome
Ages 18 to 40 · All sexes · Updated May 29, 2026 · NCT06309576Iron Absorption in The Low Oxygen Exposure and Weight Status (LOWS) Study
- Pennington Biomedical Research Center, Baton Rouge
Recruiting
Ages 22 to 65 · All sexes · Updated Apr 21, 2026 · NCT07542873Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding
- Pennington Biomedical Research Center, Baton Rouge
RecruitingHealthy volunteers welcome
Ages 18 to 42 · All sexes · Updated Apr 8, 2026 · NCT04583514Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise
- Pennington Biomedical Research Center, Baton Rouge
RecruitingHealthy volunteers welcome
Ages 18 to 45 · All sexes · Updated Mar 27, 2026 · NCT06602141Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
- Tulane University School of Public Health and Tropical Medicine, New Orleans
RecruitingHealthy volunteers welcome
Ages 18 and older · Women · Updated Jul 25, 2025 · NCT06116149International Weight Control Registry
- Pennington Biomedical Research Center, Baton Rouge
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 19, 2024 · NCT04907396From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.